Payment overview · 2025
General Payments
$765.13
12 reported records · 9 companies
Healthcare provider profile · identity verified
Husam Eddin, M.D
Allopathic & Osteopathic Physicians|Family Medicine · DAYTONA BEACH, FL · NPI 1629082607
Verified facts
What the public records show
CMS Open Payments records show Husam Eddin, M.D received $765.13 in general payments during 2025 across 12 reported records.
Madrigal Pharmaceuticals accounted for 18.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nuplazid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Nuplazid by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Nuedexta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1156 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $141.60 | 18.5% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $125.23 | 16.4% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $120.17 | 15.7% | 1 | 2025 |
| LEO Pharma Inc. | Unresolved — no canonical attribution shown | $108.20 | 14.1% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $84.17 | 11.0% | 1 | 2025 |
| Ipsen Biopharmaceuticals, Inc | Unresolved — no canonical attribution shown | $73.72 | 9.6% | 3 | 2025 |
| REVANCE THERAPEUTICS, INC. | Unresolved — no canonical attribution shown | $50.75 | 6.6% | 1 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $43.94 | 5.7% | 2 | 2025 |
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $17.35 | 2.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $765.13 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $141.60 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $125.23 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $120.17 | 1 | 2025 |
Source payment records
|
|||||
| ANZUPGO Normalized: anzupgo |
Drug | LEO Pharma Inc. | $108.20 | 1 | 2025 |
Source payment records
|
|||||
| LITFULO Normalized: litfulo |
Drug | PFIZER INC. | $84.17 | 1 | 2025 |
Source payment records
|
|||||
| IQIRVO Normalized: iqirvo |
Drug | Ipsen Biopharmaceuticals, Inc | $73.72 | 3 | 2025 |
Source payment records
|
|||||
| DAXXIFY Normalized: daxxify |
Drug | REVANCE THERAPEUTICS, INC. | $50.75 | 1 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $43.94 | 2 | 2025 |
Source payment records
|
|||||
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $17.35 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $17.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 91 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
91 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
46 | 12 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1156 | 124 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1230 | 220 |
| Eliquis | Apixaban | 1156 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 847 | 157 |
| Levothyroxine Sodium | Levothyroxine Sodium | 761 | 119 |
| Furosemide | Furosemide | 747 | 150 |
| Gabapentin | Gabapentin | 738 | 145 |
| Potassium Chloride | Potassium Chloride | 625 | 115 |
| Trazodone Hcl | Trazodone Hcl | 591 | 122 |
| Tamsulosin Hcl | Tamsulosin Hcl | 537 | 101 |
| Mirtazapine | Mirtazapine | 526 | 98 |
| Lisinopril | Lisinopril | 517 | 96 |
| Metoprolol Tartrate | Metoprolol Tartrate | 507 | 106 |
| Sertraline Hcl | Sertraline Hcl | 422 | 72 |
| Metoprolol Succinate | Metoprolol Succinate | 415 | 68 |
| Escitalopram Oxalate | Escitalopram Oxalate | 409 | 76 |
| Metformin Hcl | Metformin Hcl | 405 | 77 |
| Donepezil Hcl | Donepezil Hcl | 393 | 73 |
| Divalproex Sodium | Divalproex Sodium | 382 | 67 |
| Losartan Potassium | Losartan Potassium | 346 | 63 |
| Levetiracetam | Levetiracetam | 330 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 330 | 88 |
| Clopidogrel | Clopidogrel Bisulfate | 321 | 59 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 304 | 59 |
| Quetiapine Fumarate | Quetiapine Fumarate | 280 | 68 |
| Xarelto | Rivaroxaban | 275 | 21 |
| Carvedilol | Carvedilol | 273 | 55 |
| Memantine Hcl | Memantine Hcl | 243 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 236 | 64 |
| Lactulose | Lactulose | 217 | 36 |
| Spironolactone | Spironolactone | 188 | 39 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 180 | 27 |
| Omeprazole | Omeprazole | 179 | 42 |
| Risperidone | Risperidone | 179 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 171 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 169 | 35 |
| Midodrine Hcl | Midodrine Hcl | 169 | 35 |
| Latanoprost | Latanoprost | 164 | 33 |
| Ondansetron Hcl | Ondansetron Hcl | 148 | 47 |
| Pravastatin Sodium | Pravastatin Sodium | 145 | 21 |
| Gemtesa | Vibegron | 142 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 141 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 140 | 23 |
| Baclofen | Baclofen | 139 | 29 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 134 | 55 |
| Buspirone Hcl | Buspirone Hcl | 130 | 32 |
| Myrbetriq | Mirabegron | 126 | 13 |
| Prednisone | Prednisone | 125 | 46 |
| Montelukast Sodium | Montelukast Sodium | 122 | 20 |
| Farxiga | Dapagliflozin Propanediol | 121 | 13 |
| Bumetanide | Bumetanide | 116 | 27 |
| Finasteride | Finasteride | 112 | 24 |
| Simvastatin | Simvastatin | 111 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 110 | 23 |
| Tradjenta | Linagliptin | 108 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 105 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 105 | 38 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 104 | 20 |
| Bupropion Xl | Bupropion Hcl | 102 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 102 | 18 |
| Allopurinol | Allopurinol | 98 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 93 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 91 | 16 |
| Memantine Hcl Er | Memantine Hcl | 91 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 91 | suppressed |
| Olanzapine | Olanzapine | 91 | 18 |
| Meloxicam | Meloxicam | 90 | 16 |
| Primidone | Primidone | 88 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 87 | 36 |
| Glipizide | Glipizide | 87 | 20 |
| Lamotrigine | Lamotrigine | 85 | 11 |
| Famotidine | Famotidine | 84 | 18 |
| Methocarbamol | Methocarbamol | 83 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 82 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 80 | 23 |
| Topiramate | Topiramate | 79 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 78 | 18 |
| Clonidine Hcl | Clonidine Hcl | 78 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 78 | 13 |
| Aripiprazole | Aripiprazole | 77 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 76 | 12 |
| Januvia | Sitagliptin Phosphate | 75 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 73 | 14 |
| Entresto | Sacubitril/Valsartan | 72 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 72 | 19 |
| Warfarin Sodium | Warfarin Sodium | 72 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 20 |
| Atenolol | Atenolol | 70 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 70 | 12 |
| Nystatin | Nystatin | 69 | 31 |
| Lovastatin | Lovastatin | 66 | suppressed |
| Nifedipine Er | Nifedipine | 66 | 13 |
| Lorazepam | Lorazepam | 65 | 23 |
| Jardiance | Empagliflozin | 57 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 56 | 15 |
| Trulicity | Dulaglutide | 55 | 12 |
| Diltiazem Hcl | Diltiazem Hcl | 52 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 51 | 36 |
| Novolin R Flexpen | Insulin Regular, Human | 51 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 50 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 50 | 18 |
| Enalapril Maleate | Enalapril Maleate | 50 | suppressed |
| Levofloxacin | Levofloxacin | 50 | 36 |
| Diltiazem 24hr Er | Diltiazem Hcl | 49 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 48 | 15 |
| Tramadol Hcl | Tramadol Hcl | 48 | 18 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 47 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 46 | 17 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 46 | 12 |
| Timolol Maleate | Timolol Maleate | 46 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 45 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 44 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 44 | 20 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 44 | suppressed |
| Klor-Con 10 | Potassium Chloride | 43 | suppressed |
| Linzess | Linaclotide | 43 | suppressed |
| Scopolamine | Scopolamine | 43 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 43 | suppressed |
| Pregabalin | Pregabalin | 42 | 14 |
| Levemir Flexpen | Insulin Detemir | 41 | suppressed |
| Cephalexin | Cephalexin | 40 | 22 |
| Bupropion Hcl | Bupropion Hcl | 39 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 39 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 38 | suppressed |
| Ezetimibe | Ezetimibe | 37 | suppressed |
| Ibuprofen | Ibuprofen | 37 | 14 |
| Phenytek | Phenytoin Sodium Extended | 37 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 37 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 36 | suppressed |
| Digoxin | Digoxin | 36 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 36 | 14 |
| Incruse Ellipta | Umeclidinium Bromide | 36 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 25 |
| Xifaxan | Rifaximin | 36 | suppressed |
| Amantadine | Amantadine Hcl | 35 | suppressed |
| Clonazepam | Clonazepam | 35 | 15 |
| Sucralfate | Sucralfate | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 34 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 34 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 33 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 33 | 24 |
| Torsemide | Torsemide | 33 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 32 | 21 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 32 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | suppressed |
| Ertapenem | Ertapenem Sodium | 31 | 12 |
| Glimepiride | Glimepiride | 30 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 30 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 20 |
| Calcitriol | Calcitriol | 29 | suppressed |
| Carbamazepine | Carbamazepine | 29 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 29 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 28 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 28 | suppressed |
| Haloperidol | Haloperidol | 28 | suppressed |
| Novolog Flexpen | Insulin Aspart | 28 | suppressed |
| Alprazolam | Alprazolam | 27 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 27 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 21 |
| Enulose | Lactulose | 27 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 27 | 24 |
| Venlafaxine Hcl | Venlafaxine Hcl | 27 | suppressed |
| Admelog Solostar | Insulin Lispro | 26 | suppressed |
| Azithromycin | Azithromycin | 26 | 24 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 15 |
| Insulin Aspart Flexpen | Insulin Aspart | 25 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Celecoxib | Celecoxib | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 13 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 23 | 17 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 22 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Pentoxifylline | Pentoxifylline | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Cimetidine | Cimetidine | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 13 |
| Lidocaine Hcl | Lidocaine Hcl | 19 | 15 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | 12 |
| Labetalol Hcl | Labetalol Hcl | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 15 |
| Dapagliflozin | Dapagliflozin Propanediol | 17 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 17 | suppressed |
| Levemir | Insulin Detemir | 17 | suppressed |
| Novolin R | Insulin Regular, Human | 17 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 15 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | 12 |
| Perphenazine | Perphenazine | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Alrex | Loteprednol Etabonate | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Budesonide | Budesonide | 13 | suppressed |
| Budesonide Er | Budesonide | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Glucagon Emergency Kit | Glucagon | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Ivermectin | Ivermectin | 12 | 11 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Glyburide | Glyburide | 11 | suppressed |
| Insulin Aspart | Insulin Aspart | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Methazolamide | Methazolamide | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $765.13 · 12 records | Madrigal Pharmaceuticals | ANZUPGO, DAXXIFY, INGREZZA, IQIRVO, LITFULO, NUPLAZID, Natroba, REXULTI, REZDIFFRA, Spinosad | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nuplazid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error